Product Highlight - Ferinject
Presentation: Each 10 mL vial contains 500 mg of iron as ferric carboxymaltose.
Indication: Ferinject is indicated for treatment of iron deficiency when oral iron preparations are ineffective or cannot be used. The diagnosis of iron deficiency must be based on laboratory tests.
Dosage & Administration: The individual iron need for repletion using Ferinject is determined based on the patient’s body weight and haemoglobin (Hb) level.
|Hb||Patient body weight|
|g/dl||mmol/L||below 35 kg||35 kg to <70 kg||70 kg and above|
|<10||<6.2||500 mg||1,500 mg||2,000 mg|
|10 to <14||6.2 to <8.7||500 mg||1,000 mg||1,500 mg|
|≥14||≥8.7||500 mg||500 mg||500 mg|
The maximum recommended cumulative dose of Ferinject is 1,000 mg of iron (20 mL Ferinject) per week.
Ferinject Product information: FDA Thailand approval, April 2020